133 related articles for article (PubMed ID: 11491146)
1. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Korn SH; Jerre A; Brattsand R
Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146
[TBL] [Abstract][Full Text] [Related]
2. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
[TBL] [Abstract][Full Text] [Related]
4. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
Strandberg K; Palmberg L; Larsson K
J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826
[TBL] [Abstract][Full Text] [Related]
5. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.
Bochkov YA; Busse WW; Brockman-Schneider RA; Evans MD; Jarjour NN; McCrae C; Miller-Larsson A; Gern JE
Respir Res; 2013 Oct; 14(1):98. PubMed ID: 24219422
[TBL] [Abstract][Full Text] [Related]
6. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro.
Davies JM; Carroll ML; Li H; Poh AM; Kirkegard D; Towers M; Upham JW
PLoS One; 2011; 6(11):e27898. PubMed ID: 22125636
[TBL] [Abstract][Full Text] [Related]
7. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Eur Respir J; 2000 Jan; 15(1):68-74. PubMed ID: 10678623
[TBL] [Abstract][Full Text] [Related]
8. IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells.
Larsson S; Löfdahl CG; Linden M
Br J Pharmacol; 1999 Jun; 127(4):980-6. PubMed ID: 10433506
[TBL] [Abstract][Full Text] [Related]
9. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells.
Chiu JC; Hsu JY; Fu LS; Chu JJ; Chi CS
J Microbiol Immunol Infect; 2007 Oct; 40(5):388-94. PubMed ID: 17932597
[TBL] [Abstract][Full Text] [Related]
11. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts.
Spoelstra FM; Kauffman HF; Hovenga H; Noordhoek JA; de Monchy JG; Postma DS
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1229-34. PubMed ID: 11029322
[TBL] [Abstract][Full Text] [Related]
12. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
[TBL] [Abstract][Full Text] [Related]
13. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
Lordan JL; Bucchieri F; Richter A; Konstantinidis A; Holloway JW; Thornber M; Puddicombe SM; Buchanan D; Wilson SJ; Djukanović R; Holgate ST; Davies DE
J Immunol; 2002 Jul; 169(1):407-14. PubMed ID: 12077271
[TBL] [Abstract][Full Text] [Related]
14. Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.
Albano GD; Di Sano C; Bonanno A; Riccobono L; Gagliardo R; Chanez P; Gjomarkaj M; Montalbano AM; Anzalone G; La Grutta S; Ricciardolo FL; Profita M
PLoS One; 2013; 8(4):e58892. PubMed ID: 23573194
[TBL] [Abstract][Full Text] [Related]
15. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
[TBL] [Abstract][Full Text] [Related]
16. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics.
Profita M; Gagliardo R; Di Giorgi R; Pompeo F; Gjomarkaj M; Nicolini G; Bousquet J; Vignola AM
Allergy; 2005 Mar; 60(3):323-9. PubMed ID: 15679717
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease.
Acciani TH; Suzuki T; Trapnell BC; Le Cras TD
Clin Exp Allergy; 2016 Feb; 46(2):317-28. PubMed ID: 26263242
[TBL] [Abstract][Full Text] [Related]
18. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
19. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4.
Sasaki K; Manabe H
Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978
[TBL] [Abstract][Full Text] [Related]
20. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma.
Rüdiger JJ; Gencay M; Yang JQ; Bihl M; Tamm M; Roth M
Respirology; 2013 Jul; 18(5):840-7. PubMed ID: 23617551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
